Mount Lucas Management’s Assurant AIZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,651
Closed -$976K 161
2025
Q1
$976K Sell
4,651
-4,719
-50% -$985K 0.31% 74
2024
Q4
$2M Sell
9,370
-557
-6% -$116K 0.7% 27
2024
Q3
$1.97M Sell
9,927
-14,859
-60% -$2.71M 0.67% 35
2024
Q2
$4.12M Buy
24,786
+12,529
+102% +$2.17M 1.18% 20
2024
Q1
$2.31M Sell
12,257
-1,079
-8% -$188K 0.63% 60
2023
Q4
$2.25M Buy
+13,336
New +$2.12M 0.65% 66
2017
Q3
Sell
-99,117
Closed -$10.3M 105
2017
Q2
$10.3M Buy
99,117
+682
+0.7% +$67.9K 1.93% 19
2017
Q1
$9.42M Sell
98,435
-12,540
-11% -$1.21M 1.88% 22
2016
Q4
$10.3M Sell
110,975
-20,496
-16% -$1.79M 1.95% 21
2016
Q3
$12.1M Buy
+131,471
New +$11.5M 2.16% 10
2015
Q3
Sell
-33,648
Closed -$2.25M 94
2015
Q2
$2.25M Sell
33,648
-194,553
-85% -$12.5M 0.43% 55
2015
Q1
$14M Sell
228,201
-261,828
-53% -$16.6M 2.37% 18
2014
Q4
$33.5M Buy
490,029
+13,437
+3% +$894K 3.71% 5
2014
Q3
$30.6M Buy
476,592
+219,333
+85% +$14.3M 5.3% 3
2014
Q2
$16.9M Sell
257,259
-36,234
-12% -$2.42M 2.21% 7
2014
Q1
$19.1M Buy
+293,493
New +$19.2M 2.61% 6

Other funds holding AIZ

Mount Lucas Management's AIZ Position: Q2 2025 in Review

Mount Lucas Management sold out of Assurant (AIZ) in Q2 2025, closing a stake of 4,651 shares — an estimated $976K sold.

Mount Lucas Management first reported a position in AIZ in Q1 2014 and held it in 16 quarters. The position peaked at $33.5M in Q4 2014. 547 funds tracked by Wall St. Rank hold AIZ as of Q2 2025.

  • Mount Lucas Management reported no remaining Assurant position as of Q2 2025 after selling out during the quarter.
  • Mount Lucas Management sold 4,651 Assurant shares in Q2 2025, an estimated $976K.
  • Mount Lucas Management first reported a position in Assurant in Q1 2014 and held it in 16 quarters.
  • Mount Lucas Management's Assurant position peaked at $33.5M in Q4 2014.
  • 547 funds tracked by Wall St. Rank held Assurant as of Q2 2025.

Based on Mount Lucas Management's 13F filing for Q2 2025, filed 11 Aug 2025.